SCHEMBL822647

SCHEMBL822647

C=C(C)C(=O)OCC(COC(=O)C(=C)C)OC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 1/20 0.54
▸ CD274 Q9NZQ7 1/20 0.54
▸ SLC1A5 Q15758 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ MAPT P10636 3/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ UTS2R Q9UKP6 1/20 0.41
▸ ELANE P08246 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ APEX1 P27695 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ SERPINE1 P05121 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MMP12 P39900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21422384 0.94 PTPN1 (0.48) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL19316654 0.88 TSHR (0.42) PDCD1CD274SLC1A5KDM4EPTPN1
SCHEMBL16351900 0.87 ELANE (0.48) PDCD1CD274SLC1A5PTPN1MAPT
SCHEMBL21422393 0.83 PTPN1 (0.46) SMN1; SMN2PTPN1MAPTTSHRELANE
SCHEMBL19157831 0.83 ELANE (0.44) PDCD1CD274KDM4EPTPN1MAPT
SCHEMBL19316643 0.81 PTPN1 (0.42) SLC1A5PTPN1TSHRSERPINE1
SCHEMBL21868937 0.80 TSHR (0.36) PDCD1CD274SLC1A5SMN1; SMN2PTPN1
SCHEMBL116940 0.80 KDM4E (0.53) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL9615565 0.80 ALDH1A1 (0.45) KDM4EESR1TSHRPOLBAPEX1
SCHEMBL5846246 0.79 PTPN1 (0.48) KDM4EPTPN1MAPTTSHRELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415794-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF Showa Denko K.K. (JP) 2012-02-08 — — EP disclosed
US-20120010361-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF SHOWA DENKO K.K. (JP) 2012-01-12 — — US disclosed
US-20120010361-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF SHOWA DENKO K.K. (JP) 2012-01-12 — — US disclosed
US-20110294948-A1 AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND SHOWA DENKO K.K. (JP) 2011-12-01 — — US disclosed
US-20110294948-A1 AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND SHOWA DENKO K.K. (JP) 2011-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294948-A1 AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND ACR, MMAB, ATR PDCD1 4335/4885CD274 4447/4885SLC1A5 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback